This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Mangala Soundar
VP Biology at Judo Bio
Speaker

Profile

Mangala Soundar, PhD, leads the pre-clinical team at Judo Bio.

Prior to Judo Bio, Mangala served as Senior/Executive Director of Discovery and Preclinical Programs at PepGen, where she helped define the discovery vision, established an oligonucleotide pipeline, and led multiple neuromuscular programs. She previously headed Neuroscience at Faze Medicines, directing research strategy for a first-in-class small molecule program in ALS. Prior to that, at Alnylam Pharmaceuticals, she was preclinical lead for more than 20+ siRNA targets in the liver and CNS, helped establish the siRNA therapeutics pipeline, and contributed to programs now in the clinic including APP, HTT, and ANGPTL3.

Agenda Sessions

  • The Strike Platform Enables Kidney-Selective Gene Silencing

    9:00am